| Device |
absorbable coronary drug-eluting stent |
| Definition |
An absorbable scaffold with a drug coating placed via a delivery catheter into the coronary artery or saphenous vein graft to maintain the lumen. The drug coating is intended to inhibit restenosis. |
| Physical State |
Mesh tube in various lengths and diameters |
| Technical Method |
Provides mechanical support to the treated artery and a drug agent to prevent restenosis of the treated artery, and then gradually dissolves and is absorbed by the body. |
| Target Area |
Coronary arteries |
| Review Panel |
Cardiovascular |
| Product Code | PNY |
| Premarket Review |
Coronary and Peripheral Interventional Devices
(DHT2C)
Coronary and Peripheral Interventional Devices
(DHT2C)
|
| Submission Type |
PMA
|
| Device Class |
3
|
| Total Product Life Cycle (TPLC) |
TPLC Product Code Report
|
| GMP Exempt? |
No
|
Summary Malfunction Reporting |
Ineligible |
| Implanted Device? |
Yes
|
| Life-Sustain/Support Device? |
Yes
|
| Recognized Consensus Standards
|
| Third Party Review |
Not Third Party Eligible |